Successful Rechallenge with Osimertinib after Very Acute Onset of Drug-Induced Pneumonitis

Drug-induced interstitial lung disease (DI-ILD) is a rare, yet life-threatening complication associated with tyrosine-kinase inhibitor (TKI) therapy. Third-generation epidermal growth factor receptor-TKI, osimertinib use can be associated with a benign radiological finding called transient asymptoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed, Turab, Mangeshkar, Shaunak, Rathmann, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216030/
https://www.ncbi.nlm.nih.gov/pubmed/34177523
http://dx.doi.org/10.1159/000516274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216030/
https://www.ncbi.nlm.nih.gov/pubmed/34177523
http://dx.doi.org/10.1159/000516274

Ejemplares similares